imiquimod has been researched along with Dementias, Transmissible in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beringue, V; Blondel, M; Bouaziz, S; Contesse, MA; Desban, N; Galons, H; Massacrier, C; Morel, Y; Nguyen, PH; Oumata, N; Pang, Y; Paturel, C; Sanyal, S; Soubigou, F; Voisset, C | 1 |
| Banerjee, D; Sanyal, S | 1 |
1 review(s) available for imiquimod and Dementias, Transmissible
| Article | Year |
|---|---|
Protein folding activity of the ribosome (PFAR) -- a target for antiprion compounds.
Topics: Aminoquinolines; Binding Sites; Guanabenz; Humans; Imiquimod; Phenanthridines; Prion Diseases; Prions; Protein Folding; Ribosomes; RNA, Ribosomal | 2014 |
1 other study(ies) available for imiquimod and Dementias, Transmissible
| Article | Year |
|---|---|
The toll-like receptor agonist imiquimod is active against prions.
Topics: Aminoquinolines; Animals; Cell Line; Drug Evaluation, Preclinical; Glutathione Peroxidase; Guanosine; Humans; Imidazoles; Imiquimod; Membrane Glycoproteins; Mice; Peptide Termination Factors; Prion Diseases; Prions; Protein Folding; PrPSc Proteins; Saccharomyces cerevisiae; Saccharomyces cerevisiae Proteins; Structure-Activity Relationship; Toll-Like Receptor 7; Toll-Like Receptor 8 | 2013 |